Showing 1,656 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C treatment

New cases of hepatitis C in NYC are on the rise

Editor's pick
Politico
9 February 2016
Hepatitis C treatment

mapCrowd: an online data collection platform for hepatitis C information

Editor's pick
Treatment Action Group
9 February 2016
Organ transplants

Johns Hopkins approved to perform first HIV-positive to HIV-positive organ transplants in U.S.

Editor's pick
Johns Hopkins Medicine
9 February 2016
Hepatitis C treatment

Olysio/Sovaldi yield high SVR post-liver transplant

Editor's pick
Healio
8 February 2016
New & experimental hepatitis C treatment

Fair Pricing Coalition Recognizes Merck’s Lower Price for Curative Hepatitis C Treatment, Calls for Manufacturers to Reduce Excessive Prices and Increase Patient Assistance

Editor's pick
Fair Pricing Coalition
8 February 2016
New & experimental hepatitis C treatment

U.S. FDA Approves Expanded Use of Bristol-Myers Squibb’s Daklinza (daclatasvir) for Additional Challenging-to-treat Patients with Genotype 1 or Genotype 3 Chronic Hepatitis C

Editor's pick
Bristol-Myers Squibb press release
8 February 2016
Hepatitis C treatment

Pennsylvania to Offer Free Hepatitis C Treatment to Low-Income People With HIV

Editor's pick
Poz magazine news
5 February 2016
Activism & civil society

Lawsuits claim insurers unfairly refuse pricey hepatitis C drugs

Editor's pick
Seattle Times
3 February 2016
Hepatitis C treatment

Lawmaker: Costly hepatitis C drug "a slap in the face to veterans"

Editor's pick
CBS News
3 February 2016
Pharmaceutical industry

Merck Throws a Wrench in Drug Pricing

Editor's pick
Bloomberg
1 February 2016
New & experimental hepatitis C treatment

Zepatier for hepatitis C approved in Canada

Editor's pick
CATIE
1 February 2016
Hepatitis C treatment

European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV

Editor's pick
Bristol-Myers Squibb press release
1 February 2016
Hepatitis C treatment

Merck Prices Hepatitis C Drug Lower Than Rivals in Crowded Field

Editor's pick
Bloomberg
29 January 2016
New & experimental hepatitis C treatment

Merck Receives FDA Approval of ZEPATIER™ (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults

Editor's pick
Merck press release
29 January 2016
Hepatitis C transmission & prevention

HCV on the Rise in Dialysis Patients, CDC Warns

Editor's pick
MedPage Today HIV/AIDS
29 January 2016
Hepatitis C treatment

California Doles Out Millions to Insurers for Hepatitis C Drugs

Editor's pick
KQED News
29 January 2016
Hepatitis C treatment

Kansas Legislators Walk Back On Lifetime Ban For Hepatitis C Drugs

Editor's pick
KCUR
24 January 2016
Activism & civil society

Building patient groups for viral hepatitis – a new online resource for healthcare professionals

Editor's pick
BMC Blogs Network (blog)
22 January 2016
Hepatitis C symptoms & diagnosis

Hepatitis Testing Contest

Editor's pick
Social Entrepreneurship for Sexual Health
19 January 2016
New & experimental hepatitis C treatment

The 2016 Hepatitis C Drug Approval Outlook

Editor's pick
Poz
18 January 2016
Harm reduction

European Union Joint Action on HIV and Co - infection Prevention and Harm Reduction launched

Editor's pick
Manual Items
18 January 2016
Side effects

Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Editor's pick
Poz
14 January 2016
New & experimental hepatitis C treatment

AbbVie Initiates Enrollment of Six Global Phase 3 Clinical Studies for Once-Daily, Pan-Genotypic Hepatitis C Regimen

Editor's pick
AbbVie press release
11 January 2016
New & experimental hepatitis C treatment

Mylan Launches Generic Harvoni® (Ledipasvir/Sofosbuvir) Under the Brand Name MyHep LVIR™ in India

Editor's pick
Mylan press release
8 January 2016